Gemcitabine/TS-1 combination chemoradiotherapy for unresectable locally advanced pancreatic cancer(Phase I study).
Phase of Trial: Phase I
Latest Information Update: 24 May 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
- 18 Jan 2014 Results presented at the 2014 Gastrointestinal Cancers Symposium.
- 17 Mar 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 14 Feb 2011 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History